Automated Content
Authoring Using AI

Generate regulatory and quality compliant documents Using MARS AI

Why Quartica

The current life sciences ecosystem is a complex layering of manual processes. This, coupled with outsourcing vendors and partners, makes the overall process error-prone, labor-intensive, and does not give management the visibility it needs. Organizations come up short on speed, efficiency, and visibility while posing high compliance, scalability, and audit readiness risks.

MARS brings capabilities that can transform the way life sciences organizations operate. Quartica’s MARS platform is designed to help companies accelerate their business processes by outsourcing the manual, resource-intensive work to an intelligent system. MARS provides accelerators and indicators that allow end users to accomplish their objectives quickly and efficiently while complying with regulatory demands worldwide.

Following are the reasons why MARS can be a foundational platform for biopharma organizations to automate end-to-end information flow, analysis/insights, and report generation with quality and compliance:

Only OOB End-to-End Solution

MARS is the only unique platform available in the market with the capability to support requirements OOB. The key to the success of MARS relative to other vendors is the embodiment of multi-year iterative development, deep safety domain subject matter expertise, lessons learned, best practices, and feedback from the safety business end users.

Shorter Project Cycle Time and Best Practices

MARS significantly cuts the overall project time, as most of the features are available OOB compared to other vendor solutions. Secondly, Gilead will benefit from the lessons learned and best practices from similar content automation implementations at other biopharmaceutical companies.

Implemented as a Solution for Audit Findings by FDA/MHRA

MARS has been implemented as a solution to address audit findings related to the clinical management process, safety reporting processes, and other related processes. It brings the benefits and lessons learned from these cumulative experiences across other projects.

Application of Advanced AI

MARS can support advanced automation concepts, including learning models to optimize content generation. These are recommended as part of our phased approach methodology.

Our Champions Speak

    We had received an audit finding by the MHRA and needed to resolve the finding to satisfy an internal commitment. Quartica was able to implement MARS to meet our internal commitment and generate one-click reports for auditors which were very useful in audits and inspections

    Top 10 Pharma company

      We have been searching for a solution for our automated aggregate reporting needs for 3 years and were unable to find one until we discovered MARS which exceeded our expectations

      Top 10 Pharma company

        MARS is clearly the future of document writing for biopharma companies. This is certainly the way to go and how to write aggregate reports

        Top 10 Biopharma company

          I would like to point out that me and my team were amazed by the opportunities that MARS platform provides and we highly appreciate your contribution.

          Top 25 Generics Pharma company

          Scroll to Top